Search results for "structures"

showing 10 items of 4815 documents

A case-control study on risk factors for nuclear, cortical and posterior subcapsular cataract: The Casteldaccia Eye Study

2005

. Purpose: To investigate risk factors for nuclear, cortical and posterior subcapsular age-related cataract. Methods: A case-control study was carried out on subjects aged 40 years and older, living in Casteldaccia, Sicily. Twenty-seven potential risk factors were investigated. Nuclear, cortical and posterior subcapsular opacities of the lens were classified according to the Lens Opacities Classification System II. Subjects with advanced lens opacities represented the cases, while an identical number of subjects without or with early cataract, matched for sex and age, were recruited as controls from within the same population. Results: Univariate analysis showed that myopia and iris atrophy…

medicine.medical_specialtyeducation.field_of_studygenetic structuresbusiness.industryPopulationIris atrophyCase-control studyPseudoexfoliation syndromemedicine.diseaseeye diseasesSurgeryOphthalmologyAtrophyOphthalmologyEpidemiologymedicinesense organsPosterior subcapsular cataractRisk factoreducationbusinessActa Ophthalmologica Scandinavica
researchProduct

Antiphosphatidylserine Antibodies Affect Rat Yolk Sacs in Culture: a Mechanism for Fetal Loss in Antiphospholipid Syndrome

2004

PROBLEM: A variety of reproductive impairments have been reported in the context of the antiphospholipid syndrome (APS). APS is associated with the presence of antibodies to negatively charged phospholipids that may affect the outcome of pregnancy. METHOD OF STUDY: Rat embryos were cultured within their yolk sacs. The effects of two antiphosphatidylserine monoclonal aPS antibodies (HL5B, RR7F) regarding their influence on growth and apoptotic events of the yolk sacs, as well as on growth and the morphology of the embryos, were studied. RESULTS: Exposure of rat embryos and their yolk sacs to aPS inhibited yolk sac growth. Moreover, increased number of apoptotic events of giant cells in the a…

medicine.medical_specialtyfood.ingredientbiologyImmunologyObstetrics and GynecologyContext (language use)Embryomedicine.diseasefoodEndocrinologymedicine.anatomical_structureReproductive MedicineApoptosisGiant cellAntiphospholipid syndromeInternal medicineYolkembryonic structuresmedicinebiology.proteinImmunology and AllergyAntibodyYolk sacAmerican Journal of Reproductive Immunology
researchProduct

Elevated intraocular pressure induces neuron-specific β-III-tubulin expression in non-neuronal vascular cells.

2019

Purpose Pathological alterations within optic nerve axons and progressive loss of the parental retinal ganglion cell (RGC) bodies are characteristics of glaucomatous neuropathy. Abnormally elevated intraocular pressure (IOP) is thought to be the major risk factor for most forms of glaucomatous changes, while lowering of the IOP is the mainstream of treatment. However, the pathophysiological mechanisms involved in neurodegenerative changes are poorly understood. It remains still a matter of debate whether elevated IOP harms the neurons directly or indirectly through alterations in the retinal vascularization. Methods We analysed morphological and molecular changes within the retina exposed t…

medicine.medical_specialtygenetic structures03 medical and health scienceschemistry.chemical_compound0302 clinical medicineIn vivoInternal medicinemedicineRetinabusiness.industryRetinalGeneral Medicineeye diseasesOphthalmologyEndocrinologymedicine.anatomical_structurechemistryRetinal ganglion cellCell culture030221 ophthalmology & optometryOptic nerveDesminsense organsNeuronbusiness030217 neurology & neurosurgeryActa ophthalmologicaReferences
researchProduct

The LDL receptor in the retina: the missing link in aging, the new target in dietary prevention

2012

National audience; Purpose: The discovery of the LDL receptor (LDLR) in 1985 by Brown and Goldstein was awarded by a Nobel Prize. The LDLR has initially been identified for its role in mediating the endocytosis of LDL particles in the vascular endothelium. The deposition of lipids, including cholesterol and cholesteryl esters in Bruch’s Membrane in the one hand, and in the vessel intima in the other hand, is one of the common features of age related macular degeneration (AMD) and cardiovascular disease (CVD). Dietary habits with high intakes of omega 3 long chain fatty acids (LCFA) have been associated with AMD prevention. Similar effects have been demonstrated in CVD prevention. The mechan…

medicine.medical_specialtygenetic structures030309 nutrition & dieteticsLinoleic acidEndocytosis03 medical and health scienceschemistry.chemical_compound0404 agricultural biotechnologyInternal medicineGene expressionmedicinecardiovascular diseases[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs0303 health sciencesRetinaCholesterolbusiness.industry04 agricultural and veterinary sciencesGeneral MedicineMacular degenerationmedicine.disease040401 food scienceeye diseases3. Good healthOphthalmologyEndocrinologymedicine.anatomical_structurechemistryHumanized mouseLDL receptorlipids (amino acids peptides and proteins)sense organsbusiness[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Phosphodiesterase10A: abundance and circadian regulation in the retina and photoreceptor of the rat.

2011

Phosphodiesterase10A (PDE10A) is a dual specific cyclic nucleotide phosphodiesterase that is specifically enriched in striatum and which has gained attention as a therapeutic target for psychiatric disorders. The present study shows that PDE10A is also highly expressed in retinal neurons including photoreceptors. The levels of PDE10A transcript and protein display daily rhythms which could be seen in preparations of the whole retina. Corresponding changes in PDE10A mRNA were seen in photoreceptors isolated using laser microdissection. This suggests that the expressional control of the photoreceptor Pde10a gene contributes to the observed cyclicity in the amount of retinal PDE10A. The daily …

medicine.medical_specialtygenetic structuresAANATBlotting WesternContext (language use)Biologychemistry.chemical_compoundCyclic nucleotideInternal medicinemedicineAnimalsImmunoprecipitationCircadian rhythmRNA MessengerMolecular BiologyLaser capture microdissectionRetinaMicroscopy ConfocalPhosphoric Diester HydrolasesReverse Transcriptase Polymerase Chain ReactionGeneral NeuroscienceLasersRetinalCell biologyCircadian RhythmRatsLight intensityEndocrinologymedicine.anatomical_structurechemistrysense organsNeurology (clinical)Nucleotides CyclicMicrodissectionDevelopmental BiologyPhotoreceptor Cells VertebrateBrain research
researchProduct

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study

2011

The purpose of this study was to evaluate the effectiveness of intravitreal ranibizumab (Lucentis, Genentech, South San Francisco, Calif, USA) combined with cataract surgery for the prevention of clinically significant macular edema (CSME) in patients with diabetic retinopathy (DR). This prospective interventional case series included fifty-four eyes of 54 patients with a previous diagnosis of nonproliferative diabetic retinopathy (NPDR) without macular edema preoperatively. Subjects were assigned in a 1 : 1 ratio to receive an intraoperative intravitreal ranibizumab injection (n=27) or not (control group,n=27) associated with standardised phacoemulsification surgery. The main outcome measu…

medicine.medical_specialtygenetic structuresArticle Subjectbusiness.industrymedicine.medical_treatmentIncidence (epidemiology)After cataractPhacoemulsificationDiabetic retinopathyCataract surgerymedicine.diseaseeye diseasesSurgeryOphthalmologylcsh:Ophthalmologylcsh:RE1-994OphthalmologymedicineClinical StudyIn patientIntravitreal ranibizumabbusinessMacular edemaJournal of Ophthalmology
researchProduct

Secondary Vitrectomy with Internal Limiting Membrane Plug due to Persistent Full-Thickness Macular Hole OCT-Angiography and Microperimetry Features: …

2020

Purpose. To study the features in OCT-angiography and microperimetry in eyes with persistent full-thickness macular hole (FTMH) closed with the secondary plana vitrectomy (PPV) with autologous internal limiting membrane (ILM) plug. Methods. Secondary PPV was performed with closing the persistent FTMH with ILM plug, C3F8 tamponade, and face-down positioning. Four patients were followed for 6 months with best corrected visual acuity (BCVA) measurement, SD-OCT and OCT-A, and microperimetry. The results were compared with the fellow eye; in two patients, it was the healthy eye, and in two remaining eyes, successfully closed FTMH after primary PPV. Results. ILM flap was integrated in all cases w…

medicine.medical_specialtygenetic structuresArticle Subjectmedicine.medical_treatmentVitrectomyOCT macular hole03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFovealOphthalmologymedicineFull-thickness macular holeMacular holebusiness.industryInternal limiting membraneRetinalRE1-994medicine.diseaseeye diseasesOphthalmologychemistryClinical Study030221 ophthalmology & optometryTamponadesense organsbusinessMicroperimetry030217 neurology & neurosurgery
researchProduct

Perampanel and Visuospatial Skills in Children With Epilepsy

2021

Introduction: Perampanel (PER) is a non-competitive AMPA glutamate receptor antagonist approved for focal and generalized seizures as add-on therapy. PER does not seem to negatively affect the cognitive profile in children and adolescents, but its influence on visuospatial abilities is still to be assessed. The aim of our study was to assess visuospatial skills through a standardized neuropsychological evaluation in adolescents taking PER for 12 months.Methods: Our sample included 46 adolescents aged 12–18 years with focal and generalized drug-resistant epilepsy already in therapy with one or two antiseizure medications. Changes in visuospatial perception and memory were assessed by the Rey…

medicine.medical_specialtygenetic structuresAudiologybehavioral disciplines and activitiesSpatial memory050105 experimental psychology03 medical and health sciencesPerampanelchemistry.chemical_compound0302 clinical medicineperampanelchildrenmedicineadverse effects children perampanel tolerability visuospatial memory0501 psychology and cognitive sciencesGlutamate receptor antagonisttolerabilityRC346-429Original Researchbusiness.industry05 social sciencesNeuropsychologyCognitionExecutive functionsNeurologychemistryVisuospatial perceptionAdjunctive treatmentadverse effectsvisuospatial memoryNeurology. Diseases of the nervous systemNeurology (clinical)business030217 neurology & neurosurgery
researchProduct

Evolving European guidance on the medical management of neovascular age related macular degeneration

2006

BACKGROUND: Until recently, only two options were available for the treatment of choroidal neovascularisation (CNV) associated with age related macular degeneration (AMD)-thermal laser photocoagulation and photodynamic therapy with verteporfin (PDT-V). However, new treatments for CNV are in development, and data from phase III clinical trials of some of these pharmacological interventions are now available. In light of these new data, expert guidance is required to enable retina specialists with expertise in the management of AMD to select and use the most appropriate therapies for the treatment of neovascular AMD. METHODS: Consensus from a round table of European retina specialists was obt…

medicine.medical_specialtygenetic structuresBevacizumabAntibodies Monoclonal HumanizedTriamcinolone AcetonideMacular DegenerationCellular and Molecular NeuroscienceRanibizumabOphthalmologymedicineHumansPregnadienediolsEvidence-Based Medicinemedicine.diagnostic_testbusiness.industryAntibodies MonoclonalAptamers NucleotideMacular degenerationFluorescein angiographymedicine.diseaseVerteporfinChoroidal Neovascularizationeye diseasesSensory SystemsOphthalmologyTreatment Outcomemedicine.anatomical_structureChoroidal neovascularizationPhotochemotherapyPerspectivesense organsAnecortave acetateChoroidRanibizumabmedicine.symptombusinessmedicine.drugBritish Journal of Ophthalmology
researchProduct

Modelling cardiac mechanics of left ventricular noncompaction

2020

Left ventricular noncompaction (LVNC) can be defined as a cardiomyopathy characterised by a pattern of prominent trabecular structure and deep intertrabecular recesses, that is thought to be caused by an arrest of normal endomyocardial morphogenesis. Using patient-specific computational modelling, we assessed the cardiac mechanics of five patients with LVNC and compared myocardial stress and pump performance to those of healthy controls. Findings shown that patients with LVNC have impaired left ventricular (LV) function, making it possible that the lack of fibre shortening of noncompacted layer can determine poor heart function. Pronounced end-systolic wall stress on left ventricular wall o…

medicine.medical_specialtygenetic structuresBiomedical EngineeringComputational MechanicsCardiomyopathy02 engineering and technology030218 nuclear medicine & medical imaging03 medical and health sciencesWall stress0302 clinical medicinecardiac mechanics finite element analysis Left ventricular noncompaction wall stressInternal medicine0202 electrical engineering electronic engineering information engineeringmedicineRadiology Nuclear Medicine and imagingbusiness.industryfungifood and beveragesmedicine.diseaseComputer Science ApplicationsCardiologyLeft ventricular noncompaction020201 artificial intelligence & image processingsense organsbusinessCardiac mechanics
researchProduct